Home › Trial NCT07121478
Patients With High-grade Pancreatic Neuroendocrine Tumors
- Trial IDNCT07121478
- StatusEnrolling By Invitation
- PhasePhase 2
- Study typeInterventional
- SponsorNational Cancer Center, Korea
- Enrollment46
- Start date2025-09-23
- ConditionsNeuroendocrine Tumor of Pancreas · Pancreatic Neuroendocrine Tumors
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.